Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.
Visit our Writing Guide or this topic page for additional help.
Timeline
People
Name
Role
LinkedIn
Further reading
Title
Author
Link
Type
Date
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
News
Title
Author
Date
Publisher
Description
Cantor Fitzgerald, L.P.
June 8, 2021
www.prnewswire.com:443
/PRNewswire/ -- Cantor Fitzgerald Investment Advisors, L.P., a subsidiary of Cantor Fitzgerald, L.P. providing investment and advisory solutions to global...
M3-Brigade Acquisition II Corp.
March 9, 2021
www.prnewswire.com:443
/PRNewswire/ -- M3-Brigade Acquisition II Corp. (NYSE: MBAC, the "Company") announced today that it has closed its initial public offering of 40,000,000 units...
Mission Advancement Corp.
March 6, 2021
www.prnewswire.com:443
/PRNewswire/ -- Mission Advancement Corp. (the "Company" or "MAC") today announced that it closed its upsized initial public offering ("IPO") of 34,500,000...
M3-Brigade Acquisition II Corp.
March 4, 2021
www.prnewswire.com:443
/PRNewswire/ -- M3-Brigade Acquisition II Corp. (NYSE: MBAC, the "Company") announced today that it priced its initial public offering of 40,000,000 units at a...
Mission Advancement Corp
March 3, 2021
www.prnewswire.com:443
/PRNewswire/ -- Mission Advancement Corp. (the "Company" or "MAC") today announced the pricing of its initial public offering ("IPO") of 30,000,000 units at a...
VolitionRx Limited
February 9, 2021
www.prnewswire.com:443
/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company that applies its NucleosomicsTM platform through its...
I-Mab
February 5, 2021
www.prnewswire.com:443
/PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization...
DURECT Corporation
February 4, 2021
www.prnewswire.com:443
/PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) ("DURECT"), a biopharmaceutical company committed to transforming the treatment of acute organ injury and...
DURECT Corporation
February 3, 2021
www.prnewswire.com:443
/PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) ("DURECT"), a biopharmaceutical company committed to transforming the treatment of acute organ injury and...
SVF Investment Corp
January 25, 2021
www.prnewswire.com:443
/PRNewswire/ -- SVF Investment Corp. (Nasdaq: SVFAU) (the "Company") announced today that commencing January 25, 2021, holders of the 60,375,000 units sold in...
AcelRx Pharmaceuticals, Inc.
January 19, 2021
www.prnewswire.com:443
/PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...
Provention Bio, Inc.
January 14, 2021
www.prnewswire.com:443
/PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today...
Provention Bio, Inc.
January 12, 2021
www.prnewswire.com:443
/PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today...
View, Inc.; CF Finance Acquisition Corp. II
November 30, 2020
www.prnewswire.com:443
/PRNewswire/ -- View, Inc. ("View"), a Silicon Valley-based smart window company, and CF Finance Acquisition Corp. II (Nasdaq: CFII) ("CF II"), a special...
GCM Grosvenor; CF Finance Acquisition Corp.
November 17, 2020
www.prnewswire.com:443
/PRNewswire/ -- GCM Grosvenor, a global alternative asset management firm, and CF Finance Acquisition Corp. ("CFAC") (NASDAQ: CFFA) announced today that they...
JD Alois
June 17, 2020
Crowdfund Insider
Click HERE to find out ⭐ Pagaya Completes $200 Million ABS Led by Cantor Fitzgerald, Raises $102 Million Series D. | Crowdfund Insider: Global Fintech News, including Crowdfunding, Blockchain and more.
Bloomberg
February 5, 2020
@bsindia
Cantor Fitzgerald is led by Anshu Jain, the former co-CEO of Deutsche Bank AG
Lydia Ramsey
December 10, 2019
Business Insider
In five years, Google's imprint on the healthcare system could be a lot more present than it even is today.
Marley Jay
October 28, 2019
Business Insider
Peter Cecchini of Cantor Fitzgerald has been 2019's biggest stock-market bear. He says weakening manufacturing and consumer trends signal a sell-off.
Brad Perriello
March 27, 2019
MassDevice
The Medical Device Business Journal -- Medical Device News & Articles | MassDevice
SHOW MORE
Is a
